Article ; Online: Prevention of bleomycin-induced lung fibrosis via inhibition of the MRTF/SRF transcription pathway.
Pharmacology research & perspectives
2022 Volume 10, Issue 6, Page(s) e01028
Abstract: Bleomycin-induced lung fibrosis is a debilitating disease, linked to high morbidity and mortality in chemotherapy patients. The MRTF/SRF transcription pathway has been proposed as a potential therapeutic target, as it is critical for myofibroblast ... ...
Abstract | Bleomycin-induced lung fibrosis is a debilitating disease, linked to high morbidity and mortality in chemotherapy patients. The MRTF/SRF transcription pathway has been proposed as a potential therapeutic target, as it is critical for myofibroblast differentiation, a hallmark of fibrosis. In human lung fibroblasts, the MRTF/SRF pathway inhibitor, CCG-257081, effectively decreased mRNA levels of downstream genes: smooth muscle actin and connective tissue growth factor, with IC |
---|---|
MeSH term(s) | Humans ; Animals ; Mice ; Bleomycin/toxicity ; Pulmonary Fibrosis/chemically induced ; Pulmonary Fibrosis/drug therapy ; Pulmonary Fibrosis/prevention & control ; Inflammation ; Fibroblasts ; Prednisolone |
Chemical Substances | Bleomycin (11056-06-7) ; Prednisolone (9PHQ9Y1OLM) |
Language | English |
Publishing date | 2022-11-24 |
Publishing country | United States |
Document type | Journal Article ; Research Support, N.I.H., Extramural |
ZDB-ID | 2740389-0 |
ISSN | 2052-1707 ; 2052-1707 |
ISSN (online) | 2052-1707 |
ISSN | 2052-1707 |
DOI | 10.1002/prp2.1028 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.